John M. Wesolowski - Jul 19, 2023 Form 4 Insider Report for INTENSITY THERAPEUTICS, INC. (INTS)

Role
Interim CFO
Signature
/s/ Daniel L. Woodard, Attorney-in-Fact
Stock symbol
INTS
Transactions as of
Jul 19, 2023
Transactions value $
$0
Form type
4
Date filed
7/21/2023, 04:11 PM
Previous filing
Jun 29, 2023
Next filing
Mar 7, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INTS Stock Option (right to buy Common Stock) Award $0 +50K $0.00 50K Jul 19, 2023 Common Stock 50K $6.43 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option will vest, subject to the individual's continued employment with Intensity Therapeutics, Inc., according to the following schedule: 25% will vest on July 19, 2023, and the remaining 75% will vest in three, equal, annual installments, beginning on July 19, 2024.